查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1933369

全球猫疫苗市场：市场规模、占有率、成长率、产业分析、依类型、应用和地区划分的考虑因素以及未来预测（2026-2034）

Feline Vaccines Market Size, Share, Growth and Global Industry Analysis By Type & Application, Regional Insights and Forecast to 2026-2034
出版日期: | 出版商: Fortune Business Insights Pvt. Ltd. | 英文 167 Pages | 商品交期: 请询问到货日

价格

猫疫苗市场成长因素

预计2025年全球猫疫苗市场规模将达到16.7亿美元，2026年将成长至17.6亿美元，到2034年将达到32.1亿美元，预测期内复合年增长率（CAGR）为7.83%。北美地区将在2025年占42.77%的市场占有率，这主要得益于猫咪饲养率的上升、先进的医疗保健基础设施以及宠物主人预防保健意识的增强。猫疫苗可以保护猫咪免受猫泛白血球减少症、猫呼吸道疾病、猫杯状病毒、疱疹病毒、狂犬病和猫白血病病毒（FeLV）等严重疾病的侵害。 这些疾病在全球日益普遍，加上兽医服务和研究计画的增加，正在推动市场扩张。

像硕腾服务有限公司 (Zoetis Services LLC)、默克公司 (Merck & Co., Inc.) 和礼来动保 (Elanco) 这样的领先公司正专注于研发能够提供更广泛保护和更持久免疫力的创新疫苗，从而进一步加速市场成长。例如，一项在义大利坎帕尼亚地区（2019-2021 年）进行的研究发现，在接受检测的 328 隻宠物猫中，73.5% 的猫猫泛白血球减少症病毒检测呈阳性，这表明市场对积极的疫苗接种计划有着很高的需求。

市场动态

成长因素：猫疫苗市场的成长主要受养猫家庭数量的增加和医疗需求的扩大所驱动。 根据美国宠物用品协会 (APPA) 2023-2024 年的报告，美国养猫家庭数量将达到 4,900 万户，占所有宠物家庭的 37%。此外，狂犬病和猫白血病病毒 (FeLV) 等猫科疾病的日益流行，提高了宠物主人为猫咪接种疫苗的意愿，从而推动了市场扩张。

限制因素：发展中地区兽医服务资源有限是主要限制因素。例如，截至 2022 年，肯亚只有 410 名兽医，这限制了疫苗的普及。

机会：政府主导的猫咪疫苗接种计划提供了成长机会。 2025 年 7 月，印度纳西克市政府启动了流浪猫绝育和狂犬病疫苗接种计划，这表明政府对预防人畜共患病传播的支持力度正在加强。

挑战：由于担心安全性和副作用以及缺乏相关知识，宠物主人对疫苗接种犹豫不决，这阻碍了市场成长。美国兽医协会 (AVMA) 在 2024 年 1 月报告称，一些猫主人仍然不愿意给宠物接种疫苗，这影响了疫苗接种率。

市场趋势

猫科疾病疫苗平台的创新是关键趋势。例如，默克公司在 2024 年 9 月扩展了其 NOBIVAC NXT 平台，使其能够覆盖猫白血病病毒 (FeLV)，从而提供更高级的保护。这项进展表明，人们正致力于研发高效、持久且安全的猫用疫苗。

市场区隔分析

依技术分类：

  • 灭活​​疫苗因其安全性高且政府支持的项目（尤其是狂犬病控制项目）占主导地位。 2024年3月，默克公司根据 "狂犬病使命" 计画捐赠了NOBIVAC狂犬病疫苗。
  • 减毒活疫苗越来越多地用于猫泛白血球减少症等疾病。
  • 例如，由于技术进步和猫科疾病日益普遍，重组疫苗预计将快速增长。

依疾病类型分类：

  • 受人畜共通传染病风险的影响，狂犬病将在2024年占最大占有率。 根据美国兽医协会 (AVMA) 的数据，2023 年美国共确诊 222 例猫狂犬病病例。
  • 预计猫白血病病毒 (FeLV) 的发生率将显着上升。智利的一项研究发现，182 隻宠物猫中有 54.9% 感染了 FeLV。
  • 猫病毒性鼻气管炎和其他疾病的发生率正以中等速度增长。

依给药途径：

  • 由于其高效且起效迅速，注射疫苗越来越受欢迎。
  • 由于其给药过程无压力且免疫反应迅速，鼻腔疫苗越来越受欢迎。例如，礼来公司的猫用超强鼻腔疫苗 (Feline UltraNasal FVRCP) 可预防三种最常见的猫科疾病。

依分销管道划分：

  • 兽医诊所是主要市场，主要得益于宣传活动和合作关係，例如 Virbac 与 WSAVA 于 2022 年 10 月达成的合作。
  • 得益于 Petco Lab 于 2025 年 3 月开展的免费疫苗接种活动等举措，兽医诊所正呈现扩张迹象。
  • 药局和其他通路也预计将稳定成长，因为它们能够提供便利的疫苗接种途径。

区域展望

  • 北美：预计到 2025 年，北美市场规模将达到 7.1 亿美元，这主要得益于较高的猫咪饲养率和先进的兽医服务。美国将占该地区最大的市场占有率。
  • 欧洲：预计欧洲市场将强劲成长，这主要得益于英国 1,080 万隻宠物猫的数量（PDSA 2024）。
  • 亚太地区：由于公众意识的提高和宠物猫数量的增加，预计将实现最高的复合年增长率。预计到2024年，澳洲将拥有490万隻宠物猫。
  • 中东、非洲和拉丁美洲：由于政府主导的疫苗接种计划（例如，将于2025年2月启动的阿布达比动物福利倡议），预计将实现温和成长。

目录

第一章：引言

第二章：摘要整理

第三章：市场动态

  • 市场驱动因素
  • 市场限制因素
  • 市场机遇
  • 市场趋势

第四章：关键考虑因素

  • 猫科疾病概述：依主要国家和地区划分（2025 年）
  • 监理现况：依主要国家及地区划分（2025 年）
  • 猫科疾病疫苗接种概述
  • 新科技应用：依主要公司划分
  • 关键趋势：併购、业务合作等等。

第五章 全球猫科动物疫苗市场分析：洞察与预测（2021-2034）

  • 市场分析、洞察与预测：依技术分类
    • 灭活​​疫苗
    • 减毒活疫苗
    • 重组疫苗
    • 其他
  • 市场分析、洞察与预测：依疾病类型分类
    • 猫咪病毒性鼻气管炎
    • 狂犬病疫苗
    • 猫白血病病毒疫苗
    • 其他
  • 市场分析、洞察与预测：依给药途径分类
    • 肠外给药
    • 鼻腔给药
  • 市场分析、洞察与预测：依通路分类
    • 兽医院
    • 兽医诊所
    • 药局和药局
    • 其他
  • 市场分析、洞察与预测：依地区划分
    • 北美
    • 欧洲
    • 亚太地区
    • 拉丁美洲
    • 中东和非洲

第六章 北美猫疫苗市场分析：洞察与预测（2021-2034）

  • 依国家划分
    • 美国
    • 加拿大

第七章 欧洲猫疫苗市场分析：洞察与预测（2021-2034）

  • 依国家划分
    • 德国
    • 美国王国
    • 法国
    • 义大利
    • 西班牙
    • 斯堪的纳维亚
    • 其他欧洲国家

第八章 亚太地区猫疫苗市场分析：洞察与预测（2021-2034）

  • 依国家划分
    • 中国
    • 日本
    • 印度
    • 澳大利亚
    • 东南亚
    • 亚太其他地区

第九章 拉丁美洲猫疫苗市场分析：洞察与预测（2021-2034）

  • 依国家划分
    • 巴西
    • 墨西哥
    • 拉丁美洲其他地区

章节10：中东与非洲猫疫苗市场分析：洞察与预测（2021-2034）

  • 依国家划分
    • 海湾合作委员会 (GCC) 国家
    • 南非
    • 中东和非洲其他地区

第 11 章 竞争分析

  • 全球市占率分析（2025）
  • 公司简介
  • Elanco
  • Boehringer Ingelheim International GmbH
  • Virbac
  • Merck &Co., Inc.
  • Zoetis Services LLC
  • Ceva
  • Bioveta, a.s.
Product Code: FBI113898

Growth Factors of feline vaccines Market

The global feline vaccines market was valued at USD 1.67 billion in 2025 and is projected to grow to USD 1.76 billion in 2026, reaching USD 3.21 billion by 2034, reflecting a CAGR of 7.83% during the forecast period. North America dominated the market in 2025 with a 42.77% share, driven by rising cat ownership, advanced veterinary healthcare infrastructure, and awareness among pet owners regarding preventive care. Feline vaccines protect cats from serious illnesses such as feline panleukopenia, feline respiratory diseases, calicivirus, herpesvirus, rabies, and feline leukemia virus (FeLV). The increasing prevalence of these diseases globally, coupled with the growth of veterinary services and research initiatives, is propelling the market's expansion.

Key players such as Zoetis Services LLC, Merck & Co., Inc., and Elanco have been focusing on innovative vaccines offering broader protection and longer-lasting immunity, thus further accelerating market growth. For example, a study conducted in Campania, Italy (2019-2021) revealed that 73.5% of 328 domestic cats tested positive for feline panleukopenia virus, indicating high demand for active vaccination programs.

Market Dynamics

Drivers: The growth of the feline vaccines market is largely driven by rising cat ownership and the increasing demand for preventive healthcare. In 2023-2024, the American Pet Products Association reported 49 million U.S. households owning a cat, representing 37% of pet-owning households. Additionally, the rising prevalence of feline diseases like rabies and FeLV encourages owners to vaccinate their pets, fueling market expansion.

Restraints: Limited access to veterinary services in developing regions poses a significant restraint. For example, in Kenya, only 410 veterinarians were available in 2022, limiting vaccine adoption.

Opportunities: Government initiatives for feline vaccination present growth opportunities. In July 2025, Nashik Municipal Corporation (India) launched a program to sterilize and vaccinate stray cats against rabies, reflecting increasing institutional support to prevent zoonotic disease spread.

Challenges: Vaccine hesitancy among pet owners, due to concerns over safety, side effects, and awareness gaps, continues to challenge market growth. The AVMA reported in January 2024 that some cat owners remain reluctant to vaccinate their pets, impacting adoption rates.

Market Trends

Innovations in vaccine platforms for feline diseases are a key trend. For instance, in September 2024, Merck & Co., Inc. expanded its NOBIVAC NXT platform to include FeLV, offering advanced protection against feline leukemia virus. Such developments demonstrate a focus on high-efficacy, long-lasting, and safer vaccines for cats.

Segmentation Analysis

By Technology:

  • Inactivated vaccines dominate due to high safety profiles and government-supported programs, particularly against rabies. In March 2024, Merck donated NOBIVAC rabies vaccines under the Mission Rabies initiative.
  • Live attenuated vaccines are increasingly used for diseases like feline panleukopenia.
  • Recombinant vaccines and others are projected to grow rapidly due to technological advancements and rising prevalence of feline diseases.

By Disease Type:

  • Rabies held the largest share in 2024, driven by zoonotic risks. AVMA reported 222 rabies cases in cats in 2023.
  • Feline leukemia virus (FeLV) is expected to grow significantly; a survey in Chile reported FeLV prevalence of 54.9% among 182 domestic cats.
  • Feline viral rhinotracheitis and other diseases are growing at a moderate pace.

By Route of Administration:

  • Parenteral vaccines dominate due to higher efficacy and rapid onset.
  • Intranasal vaccines are expanding due to stress-free administration and quick immune response. For example, Elanco's Feline UltraNasal FVRCP vaccine protects against three major diseases in cats.

By Distribution Channel:

  • Veterinary hospitals dominate, driven by awareness campaigns and partnerships such as Virbac with WSAVA in October 2022.
  • Veterinary clinics are expanding with initiatives like Petco Love's free vaccination drive in March 2025.
  • Pharmacies and other channels are expected to grow steadily, offering convenient access to vaccines.

Regional Outlook

  • North America: Market valued at USD 0.71 billion in 2025, driven by high cat ownership and advanced veterinary services. The U.S. accounts for the largest regional share.
  • Europe: Strong growth expected, with 10.8 million pet cats in the U.K. (PDSA 2024).
  • Asia Pacific: Fastest CAGR anticipated due to rising awareness and increasing number of pet cats; Australia reported 4.9 million pet cats in 2024.
  • Latin America & Middle East & Africa: Moderate growth driven by government-led vaccination programs, such as Animal Welfare Abu Dhabi initiative in February 2025.

Competitive Landscape

The market is semi-consolidated with key players like Zoetis Services LLC, Merck & Co., Inc., Elanco, Virbac, Ceva, and Boehringer Ingelheim. These companies leverage product innovation, strategic partnerships, and global presence to strengthen market position. Recent developments include:

  • August 2025: Bioveta launched Biofel vaccines for cats and Biocan for dogs in Venezuela.
  • September 2024: Merck launched NOBIVAC NXT FeLV.
  • June 2024: Merck expanded NOBIVAC NXT Rabies portfolio in Canada.

Conclusion

The global feline vaccines market is projected to grow from USD 1.67 billion in 2025 to USD 1.76 billion in 2026, reaching USD 3.21 billion by 2034 at a CAGR of 7.83%. Growth is driven by rising cat ownership, awareness of preventive care, government initiatives, and advances in vaccine technology. North America dominates, while Asia Pacific exhibits the fastest growth. Despite challenges like limited access in developing countries and vaccine hesitancy, innovations in vaccine platforms, intranasal vaccines, and strategic expansions of major players are expected to sustain market growth throughout the forecast period.

Segmentation By Technology

  • Inactivated
  • Live Attenuated
  • Recombinant
  • Others

By Disease Type

  • Feline Viral Rhinotracheitis
  • Rabies
  • Feline Leukemia Virus
  • Others

By Route of Administration

  • Parenteral
  • Intranasal

By Distribution Channel

  • Veterinary Hospitals
  • Veterinary Clinics
  • Pharmacies & Drug Stores
  • Others

By Region

  • North America (By Technology, By Disease Type, By Route of Administration, By Distribution Channel, By Country/ Sub-Region)
    • U.S.
    • Canada
  • Europe (By Technology, By Disease Type, By Route of Administration, By Distribution Channel, By Country/ Sub-Region)
    • U.K.
    • Germany
    • France
    • Italy
    • Spain
    • Scandinavia
    • Rest of Europe
  • Asia Pacific (By Technology, By Disease Type, By Route of Administration, By Distribution Channel, By Country/ Sub-Region)
    • Japan
    • China
    • India
    • Australia
    • Southeast Asia
    • Rest of Asia Pacific
  • Latin America (By Technology, By Disease Type, By Route of Administration, By Distribution Channel, By Country/ Sub-Region)
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East & Africa (By Technology, By Disease Type, By Route of Administration, By Distribution Channel, By Country/ Sub-Region)
    • GCC
    • South Africa
    • Rest of the Middle East & Africa

Table of Content

1. Introduction

  • 1.1. Research Scope
  • 1.2. Market Segmentation
  • 1.3. Research Methodology
  • 1.4. Definitions and Assumptions

2. Executive Summary

3. Market Dynamics

  • 3.1. Market Drivers
  • 3.2. Market Restraints
  • 3.3. Market Opportunities
  • 3.4. Market Trends

4. Key Insights

  • 4.1. Overview of Feline Diseases by Key Countries, By Key Countries/ Region, 2025
  • 4.2. Regulatory Scenario by Key Countries/ Region, 2025
  • 4.3. Overview of Vaccination for Feline Diseases
  • 4.4. New Technology Launches, By Key Players
  • 4.5. Key Industry Developments (Mergers, Acquisitions, Partnerships, etc.)

5. Global Feline Vaccines Market Analysis, Insights and Forecast, 2021-2034

  • 5.1. Market Analysis, Insights and Forecast - By Technology
    • 5.1.1. Inactivated
    • 5.1.2. Live Attenuated
    • 5.1.3. Recombinant
    • 5.1.4. Others
  • 5.2. Market Analysis, Insights and Forecast - By Disease Type
    • 5.2.1. Feline Viral Rhinotracheitis
    • 5.2.2. Rabies
    • 5.2.3. Feline Leukemia Virus
    • 5.2.4. Others
  • 5.3. Market Analysis, Insights and Forecast - By Route of Administration
    • 5.3.1. Parenteral
    • 5.3.2. Intranasal
  • 5.4. Market Analysis, Insights and Forecast - By Distribution Channel
    • 5.4.1. Veterinary Hospitals
    • 5.4.2. Veterinary Clinics
    • 5.4.3. Pharmacies & Drug Stores
    • 5.4.4. Others
  • 5.5. Market Analysis, Insights and Forecast - Region
    • 5.5.1. North America
    • 5.5.2. Europe
    • 5.5.3. Asia Pacific
    • 5.5.4. Latin America
    • 5.5.5. Middle East & Africa

6. North America Feline Vaccines Market Analysis, Insights and Forecast, 2021-2034

  • 6.1. Market Analysis, Insights and Forecast - By Technology
    • 6.1.1. Inactivated
    • 6.1.2. Live Attenuated
    • 6.1.3. Recombinant
    • 6.1.4. Others
  • 6.2. Market Analysis, Insights and Forecast - By Disease Type
    • 6.2.1. Feline Viral Rhinotracheitis
    • 6.2.2. Rabies
    • 6.2.3. Feline Leukemia Virus
    • 6.2.4. Others
  • 6.3. Market Analysis, Insights and Forecast - By Route of Administration
    • 6.3.1. Parenteral
    • 6.3.2. Intranasal
  • 6.4. Market Analysis, Insights and Forecast - By Distribution Channel
    • 6.4.1. Veterinary Hospitals
    • 6.4.2. Veterinary Clinics
    • 6.4.3. Pharmacies & Drug Stores
    • 6.4.4. Others
  • 6.5. Market Analysis, Insights and Forecast - By Country
    • 6.5.1. U.S.
    • 6.5.2. Canada

7. Europe Feline Vaccines Market Analysis, Insights and Forecast, 2021-2034

  • 7.1. Market Analysis, Insights and Forecast - By Technology
    • 7.1.1. Inactivated
    • 7.1.2. Live Attenuated
    • 7.1.3. Recombinant
    • 7.1.4. Others
  • 7.2. Market Analysis, Insights and Forecast - By Disease Type
    • 7.2.1. Feline Viral Rhinotracheitis
    • 7.2.2. Rabies
    • 7.2.3. Feline Leukemia Virus
    • 7.2.4. Others
  • 7.3. Market Analysis, Insights and Forecast - By Route of Administration
    • 7.3.1. Parenteral
    • 7.3.2. Intranasal
  • 7.4. Market Analysis, Insights and Forecast - By Distribution Channel
    • 7.4.1. Veterinary Hospitals
    • 7.4.2. Veterinary Clinics
    • 7.4.3. Pharmacies & Drug Stores
    • 7.4.4. Others
  • 7.5. Market Analysis, Insights and Forecast - By Country/ Sub-Region
    • 7.5.1. Germany
    • 7.5.2. U.K.
    • 7.5.3. France
    • 7.5.4. Italy
    • 7.5.5. Spain
    • 7.5.6. Scandinavia
    • 7.5.7. Rest of Europe

8. Asia Pacific Feline Vaccines Market Analysis, Insights and Forecast, 2021-2034

  • 8.1. Market Analysis, Insights and Forecast - By Technology
    • 8.1.1. Inactivated
    • 8.1.2. Live Attenuated
    • 8.1.3. Recombinant
    • 8.1.4. Others
  • 8.2. Market Analysis, Insights and Forecast - By Disease Type
    • 8.2.1. Feline Viral Rhinotracheitis
    • 8.2.2. Rabies
    • 8.2.3. Feline Leukemia Virus
    • 8.2.4. Others
  • 8.3. Market Analysis, Insights and Forecast - By Route of Administration
    • 8.3.1. Parenteral
    • 8.3.2. Intranasal
  • 8.4. Market Analysis, Insights and Forecast - By Distribution Channel
    • 8.4.1. Veterinary Hospitals
    • 8.4.2. Veterinary Clinics
    • 8.4.3. Pharmacies & Drug Stores
    • 8.4.4. Others
  • 8.5. Market Analysis, Insights and Forecast - By Country/ Sub-Region
    • 8.5.1. China
    • 8.5.2. Japan
    • 8.5.3. India
    • 8.5.4. Australia
    • 8.5.5. Southeast Asia
    • 8.5.6. Rest of Asia Pacific

9. Latin America Feline Vaccines Market Analysis, Insights and Forecast, 2021-2034

  • 9.1. Market Analysis, Insights and Forecast - By Technology
    • 9.1.1. Inactivated
    • 9.1.2. Live Attenuated
    • 9.1.3. Recombinant
    • 9.1.4. Others
  • 9.2. Market Analysis, Insights and Forecast - By Disease Type
    • 9.2.1. Feline Viral Rhinotracheitis
    • 9.2.2. Rabies
    • 9.2.3. Feline Leukemia Virus
    • 9.2.4. Others
  • 9.3. Market Analysis, Insights and Forecast - By Route of Administration
    • 9.3.1. Parenteral
    • 9.3.2. Intranasal
  • 9.4. Market Analysis, Insights and Forecast - By Distribution Channel
    • 9.4.1. Veterinary Hospitals
    • 9.4.2. Veterinary Clinics
    • 9.4.3. Pharmacies & Drug Stores
    • 9.4.4. Others
  • 9.5. Market Analysis, Insights and Forecast - By Country/ Sub-Region
    • 9.5.1. Brazil
    • 9.5.2. Mexico
    • 9.5.3. Rest of Latin America

10. Middle East & Africa Feline Vaccines Market Analysis, Insights and Forecast, 2021-2034

  • 10.1. Market Analysis, Insights and Forecast - By Technology
    • 10.1.1. Inactivated
    • 10.1.2. Live Attenuated
    • 10.1.3. Recombinant
    • 10.1.4. Others
  • 10.2. Market Analysis, Insights and Forecast - By Disease Type
    • 10.2.1. Feline Viral Rhinotracheitis
    • 10.2.2. Rabies
    • 10.2.3. Feline Leukemia Virus
    • 10.2.4. Others
  • 10.3. Market Analysis, Insights and Forecast - By Route of Administration
    • 10.3.1. Parenteral
    • 10.3.2. Intranasal
  • 10.4. Market Analysis, Insights and Forecast - By Distribution Channel
    • 10.4.1. Veterinary Hospitals
    • 10.4.2. Veterinary Clinics
    • 10.4.3. Pharmacies & Drug Stores
    • 10.4.4. Others
  • 10.5. Market Analysis, Insights and Forecast - By Country/ Sub-Region
    • 10.5.1. GCC
    • 10.5.2. South Africa
    • 10.5.3. Rest of Middle East & Africa

11. Competitive Analysis

  • 11.1. Global Market Share Analysis (2025)
  • 11.2. Company Profiles (Overview, Technology, SWOT analysis, Recent developments, strategies, financials (based on availability))
    • 11.2.1. Elanco
    • 11.2.2. Boehringer Ingelheim International GmbH
    • 11.2.3. Virbac
    • 11.2.4. Merck & Co., Inc.
    • 11.2.5. Zoetis Services LLC
    • 11.2.6. Ceva
    • 11.2.7. Bioveta, a.s.

List of Tables

  • Table 1: Global Feline Vaccines Market Revenue (USD billion) Forecast, by Technology, 2021-2034
  • Table 2: Global Feline Vaccines Market Revenue (USD billion) Forecast, by Disease Type, 2021-2034
  • Table 3: Global Feline Vaccines Market Revenue (USD billion) Forecast, by Route of Administration, 2021-2034
  • Table 4: Global Feline Vaccines Market Revenue (USD billion) Forecast, by Distribution Channel, 2021-2034
  • Table 5: Global Feline Vaccines Market Revenue (USD billion) Forecast, by Region, 2021-2034
  • Table 6: North America Feline Vaccines Market Revenue (USD billion) Forecast, by Technology, 2021-2034
  • Table 7: North America Feline Vaccines Market Revenue (USD billion) Forecast, by Disease Type, 2021-2034
  • Table 8: North America Feline Vaccines Market Revenue (USD billion) Forecast, by Route of Administration, 2021-2034
  • Table 9: North America Feline Vaccines Market Revenue (USD billion) Forecast, by Distribution Channel, 2021-2034
  • Table 10: North America Feline Vaccines Market Revenue (USD billion) Forecast, By Country, 2021-2034
  • Table 11: Europe Feline Vaccines Market Revenue (USD billion) Forecast, by Technology, 2021-2034
  • Table 12: Europe Feline Vaccines Market Revenue (USD billion) Forecast, by Disease Type, 2021-2034
  • Table 13: Europe Feline Vaccines Market Revenue (USD billion) Forecast, by Route of Administration, 2021-2034
  • Table 14: Europe Feline Vaccines Market Revenue (USD billion) Forecast, by Distribution Channel, 2021-2034
  • Table 15: Europe Feline Vaccines Market Revenue (USD billion) Forecast, By Country/ Sub-region, 2021-2034
  • Table 16: Asia Pacific Feline Vaccines Market Revenue (USD billion) Forecast, by Technology, 2021-2034
  • Table 17: Asia Pacific Feline Vaccines Market Revenue (USD billion) Forecast, by Disease Type, 2021-2034
  • Table 18: Asia Pacific Feline Vaccines Market Revenue (USD billion) Forecast, by Route of Administration, 2021-2034
  • Table 19: Asia Pacific Feline Vaccines Market Revenue (USD billion) Forecast, by Distribution Channel, 2021-2034
  • Table 20: Asia Pacific Feline Vaccines Market Revenue (USD billion) Forecast, By Country/ Sub-region, 2021-2034
  • Table 21: Latin America Feline Vaccines Market Revenue (USD billion) Forecast, by Technology, 2021-2034
  • Table 22: Latin America Feline Vaccines Market Revenue (USD billion) Forecast, by Disease Type, 2021-2034
  • Table 23: Latin America Feline Vaccines Market Revenue (USD billion) Forecast, by Route of Administration, 2021-2034
  • Table 24: Latin America Feline Vaccines Market Revenue (USD billion) Forecast, by Distribution Channel, 2021-2034
  • Table 25: Latin America Feline Vaccines Market Revenue (USD billion) Forecast, By Country/ Sub-region, 2021-2034
  • Table 26: Middle East & Africa Feline Vaccines Market Revenue (USD billion) Forecast, by Technology, 2021-2034
  • Table 27: Middle East & Africa Feline Vaccines Market Revenue (USD billion) Forecast, by Disease Type, 2021-2034
  • Table 28: Middle East & Africa Feline Vaccines Market Revenue (USD billion) Forecast, by Route of Administration, 2021-2034
  • Table 29: Middle East & Africa Feline Vaccines Market Revenue (USD billion) Forecast, by Distribution Channel, 2021-2034

List of Figures

  • Figure 1: Global Feline Vaccines Market Revenue Breakdown (USD billion, %) by Region, 2025 & 2034
  • Figure 2: Global Feline Vaccines Market Value Share (%), by Technology, 2025 & 2034
  • Figure 3: Global Feline Vaccines Market Value Share (%), by Disease Type, 2025 & 2034
  • Figure 4: Global Feline Vaccines Market Value Share (%), by Route of Administration, 2025 & 2034
  • Figure 5: Global Feline Vaccines Market Value Share (%), by Distribution Channel, 2025 & 2034
  • Figure 6: Global Feline Vaccines Market Value Share (%), by Region, 2025 & 2034
  • Figure 7: North America Feline Vaccines Market Value (USD billion), by Technology, 2025 & 2034
  • Figure 8: North America Feline Vaccines Market Value Share (%), by Technology, 2025
  • Figure 9: North America Feline Vaccines Market Value (USD billion), by Disease Type, 2025 & 2034
  • Figure 10: North America Feline Vaccines Market Value Share (%), by Disease Type, 2025
  • Figure 11: North America Feline Vaccines Market Value (USD billion), by Route of Administration, 2025 & 2034
  • Figure 12: North America Feline Vaccines Market Value Share (%), by Route of Administration, 2025
  • Figure 13: North America Feline Vaccines Market Value (USD billion), by Distribution Channel, 2025 & 2034
  • Figure 14: North America Feline Vaccines Market Value Share (%), by Distribution Channel, 2025
  • Figure 15: North America Feline Vaccines Market Value (USD billion), By Country, 2025 & 2034
  • Figure 16: North America Feline Vaccines Market Value Share (%), By Country, 2025
  • Figure 17: Europe Feline Vaccines Market Value (USD billion), by Technology, 2025 & 2034
  • Figure 18: Europe Feline Vaccines Market Value Share (%), by Technology, 2025
  • Figure 19: Europe Feline Vaccines Market Value (USD billion), by Disease Type, 2025 & 2034
  • Figure 20: Europe Feline Vaccines Market Value Share (%), by Disease Type, 2025
  • Figure 21: Europe Feline Vaccines Market Value (USD billion), by Route of Administration, 2025 & 2034
  • Figure 22: Europe Feline Vaccines Market Value Share (%), by Route of Administration, 2025
  • Figure 23: Europe Feline Vaccines Market Value (USD billion), by Distribution Channel, 2025 & 2034
  • Figure 24: Europe Feline Vaccines Market Value Share (%), by Distribution Channel, 2025
  • Figure 25: Europe Feline Vaccines Market Value (USD billion), By Country/ Sub-region, 2025 & 2034
  • Figure 26: Europe Feline Vaccines Market Value Share (%), By Country/ Sub-region, 2025
  • Figure 27: Asia Pacific Feline Vaccines Market Value (USD billion), by Technology, 2025 & 2034
  • Figure 28: Asia Pacific Feline Vaccines Market Value Share (%), by Technology, 2025
  • Figure 29: Asia Pacific Feline Vaccines Market Value (USD billion), by Disease Type, 2025 & 2034
  • Figure 30: Asia Pacific Feline Vaccines Market Value Share (%), by Disease Type, 2025
  • Figure 31: Asia Pacific Feline Vaccines Market Value (USD billion), by Route of Administration, 2025 & 2034
  • Figure 32: Asia Pacific Feline Vaccines Market Value Share (%), by Route of Administration, 2025
  • Figure 33: Asia Pacific Feline Vaccines Market Value (USD billion), by Distribution Channel, 2025 & 2034
  • Figure 34: Asia Pacific Feline Vaccines Market Value Share (%), by Distribution Channel, 2025
  • Figure 35: Asia Pacific Feline Vaccines Market Value (USD billion), By Country/ Sub-region, 2025 & 2034
  • Figure 36: Asia Pacific Feline Vaccines Market Value Share (%), By Country/ Sub-region, 2025
  • Figure 37: Latin America Feline Vaccines Market Value (USD billion), by Technology, 2025 & 2034
  • Figure 38: Latin America Feline Vaccines Market Value Share (%), by Technology, 2025
  • Figure 39: Latin America Feline Vaccines Market Value (USD billion), by Disease Type, 2025 & 2034
  • Figure 40: Latin America Feline Vaccines Market Value Share (%), by Disease Type, 2025
  • Figure 41: Latin America Feline Vaccines Market Value (USD billion), by Route of Administration, 2025 & 2034
  • Figure 42: Latin America Feline Vaccines Market Value Share (%), by Route of Administration, 2025
  • Figure 43: Latin America Feline Vaccines Market Value (USD billion), by Distribution Channel, 2025 & 2034
  • Figure 44: Latin America Feline Vaccines Market Value Share (%), by Distribution Channel, 2025
  • Figure 45: Latin America Feline Vaccines Market Value (USD billion), By Country/ Sub-region, 2025 & 2034
  • Figure 46: Latin America Feline Vaccines Market Value Share (%), By Country/ Sub-region, 2025
  • Figure 47: Middle East & Africa Feline Vaccines Market Value (USD billion), by Technology, 2025 & 2034
  • Figure 48: Middle East & Africa Feline Vaccines Market Value Share (%), by Technology, 2025
  • Figure 49: Middle East & Africa Feline Vaccines Market Value (USD billion), by Disease Type, 2025 & 2034
  • Figure 50: Middle East & Africa Feline Vaccines Market Value Share (%), by Disease Type, 2025
  • Figure 51: Middle East & Africa Feline Vaccines Market Value (USD billion), by Route of Administration, 2025 & 2034
  • Figure 52: Middle East & Africa Feline Vaccines Market Value Share (%), by Route of Administration, 2025
  • Figure 53: Middle East & Africa Feline Vaccines Market Value (USD billion), by Distribution Channel, 2025 & 2034
  • Figure 54: Middle East & Africa Feline Vaccines Market Value Share (%), by Distribution Channel, 2025
  • Figure 55: Middle East & Africa Feline Vaccines Market Value (USD billion), By Country/ Sub-region, 2025 & 2034
  • Figure 56: Middle East & Africa Feline Vaccines Market Value Share (%), By Country/ Sub-region, 2025
  • Figure 57: Global Feline Vaccines Market Share (%), By Company, 2025